1,474
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy

, , , , , , , ORCID Icon & ORCID Icon show all
Pages 995-1003 | Received 19 Feb 2018, Accepted 03 Apr 2018, Published online: 18 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amit Lath, Anita Rani Santal, Nameet Kaur, Poonam Kumari & Nater Pal Singh. (2023) Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs. Biotechnology and Genetic Engineering Reviews 39:1, pages 45-84.
Read now

Articles from other publishers (9)

Xiaolei Guo, Yuzhen Xue, Ruixue Zheng, Shengfu Chen, Weili Xue, Xifa Lan, Longgang Wang & Haiyan Xiao. (2023) Zwitterionic doxorubicin loaded micelles based on polyethyleneimine for enhanced antitumor therapy in vivo . New Journal of Chemistry 47:24, pages 11636-11642.
Crossref
Sandeep UrandurMillicent O. Sullivan. (2023) Peptide-Based Vectors: A Biomolecular Engineering Strategy for Gene Delivery. Annual Review of Chemical and Biomolecular Engineering 14:1, pages 243-264.
Crossref
Meng Zhang, Ming Du, Xingling Qi, Yumeng Wang, Guiling Li, Congjian Xu & Xiaoyan Zhang. (2022) Retro-inversion follicle-stimulating hormone peptide-modified nanoparticles for delivery of PDK2 shRNA against chemoresistant ovarian cancer by switching glycolysis to oxidative phosphorylation. Cancer Nanotechnology 13:1.
Crossref
Wenxiu Tian, Huimin Qi, Zhimei Wang, Sen Qiao, Ping Wang, Junhong Dong & Hongmei Wang. (2022) Hormone supply to the pituitary gland: A comprehensive investigation of female‑related tumors (Review). International Journal of Molecular Medicine 50:4.
Crossref
Riya Khetan, Cintya Dharmayanti, Todd A. Gillam, Eric Kübler, Manuela Klingler-Hoffmann, Carmela Ricciardelli, Martin K. Oehler, Anton Blencowe, Sanjay Garg & Hugo Albrecht. (2022) Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines. Cancers 14:10, pages 2362.
Crossref
Nunzianna Doti, Mario Mardirossian, Annamaria Sandomenico, Menotti Ruvo & Andrea Caporale. (2021) Recent Applications of Retro-Inverso Peptides. International Journal of Molecular Sciences 22:16, pages 8677.
Crossref
Meng Zhang, Qiyu Liu, Mingxing Zhang, Cong Cao, Xiaoxia Liu, Mengyu Zhang, Guiling Li, Congjian Xu & Xiaoyan Zhang. (2020) Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism. Journal of Nanobiotechnology 18:1.
Crossref
Zhiquan Liang, Ziwen Lu, Yafei Zhang, Dongsheng Shang, Ruyan Li, Lanlan Liu, Zhicong Zhao, Peishan Zhang, Qiong Lin, Chunlai Feng, Yibang Zhang, Peng Liu, Zhigang Tu & Hanqing Liu. (2019) Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy. Current Cancer Drug Targets 19:6, pages 449-467.
Crossref
Omkar Gandbhir & Pazhani Sundaram. (2019) Pre-Clinical Safety and Efficacy Evaluation of Amytrap, a Novel Therapeutic to Treat Alzheimer’s Disease. Journal of Alzheimer's Disease Reports 3:1, pages 77-94.
Crossref